ConductScience.org, home

Paper8200548

Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.

Dent J and 7 others. Gut, 1994. Cited by 182 papers, by iCite.

Cite this record

ConductScience Library. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety. Papers, record 8200548. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8200548

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.
PubMed
Journal
Gut
PubMed
Year
1994
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
182
iCite
Relative citation ratio, by iCite
9.29
iCite
Revised in PubMed
2023-07-19
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dent JJ
2Yeomans NDN D
3Mackinnon MM
4Reed WW
5Narielvala FMF M
6Hetzel DJD J
7Solcia EE
8Shearman DJD J

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Esophagitis, PepticMajor topic
OmeprazoleMajor topic
RanitidineMajor topic
Adolescent
Adult
Aged
Aged, 80 and over
Double-Blind Method
Esophagoscopy
Esophagus
Female
Humans
Hyperplasia
Male
Middle Aged
Recurrence
Time Factors

Source PubMed

Download CSV of topics

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11397748Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth.Digestion1992https://conductscience.org/library/papers/1397748PubMed
21346769Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.Gut1992https://conductscience.org/library/papers/1346769PubMed
34185638A silver nitrate stain for alpha-2 cells in human pancreatic islets.Acta Soc Med Ups1968https://conductscience.org/library/papers/4185638PubMed
46832622Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.Gut1983https://conductscience.org/library/papers/6832622PubMed
53880557Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage.Gastroenterology1985https://conductscience.org/library/papers/3880557PubMed
63041558Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study.Scand J Gastroenterol1988https://conductscience.org/library/papers/3041558PubMed
71397749Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment.Digestion1992https://conductscience.org/library/papers/1397749PubMed
83044912Healing and relapse of severe peptic esophagitis after treatment with omeprazole.Gastroenterology1988https://conductscience.org/library/papers/3044912PubMed
93072229Histopathological classification of nonantral gastric endocrine growths in man.Digestion1988https://conductscience.org/library/papers/3072229PubMed
102350532Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects.Br J Clin Pharmacol1990https://conductscience.org/library/papers/2350532PubMed
112093018Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.Digestion1990https://conductscience.org/library/papers/2093018PubMed
121853146Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.Scand J Gastroenterol1991https://conductscience.org/library/papers/1853146PubMed
131727744Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter Study.Gastroenterology1992https://conductscience.org/library/papers/1727744PubMed
141759136Argyrophil cell hyperplasia associated with chronic corpus gastritis in gastric ulcer disease.Scand J Gastroenterol Suppl1991https://conductscience.org/library/papers/1759136PubMed

Download CSV of references

Cited by40

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 182 citations.

PMIDTitleJournalYearIn PapersSource
37876257[Diagnosis and Treatment of GastroEsophageal Reflux Disease at the Primary Health Care Clinics in Korea].Korean J Gastroenterol2023https://conductscience.org/library/papers/37876257PubMed
35683583Comparison in Adherence to Treatment between Patients with Mild-Moderate and Severe Reflux Esophagitis: A Prospective Study.J Clin Med2022https://conductscience.org/library/papers/35683583PubMed
30919071Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease.J Gastroenterol2019https://conductscience.org/library/papers/30919071PubMed
30854351Impact of Chronic Statins Use on the Development of Esophagitis in Patients with Gastroesophageal Reflux Disease.Can J Gastroenterol Hepatol2019https://conductscience.org/library/papers/30854351PubMed
28301676Deprescribing versus continuation of chronic proton pump inhibitor use in adults.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/28301676PubMed
25464111Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/25464111PubMed
23667753
A randomized, double blinded, clinical trial to assess the efficacy and cost effectiveness of omeprazole compared to rabeprazole in the maintenance therapy of patients with gastroesophageal reflux disease.
J Neurogastroenterol Motil2013https://conductscience.org/library/papers/23667753PubMed
19450297GORD in adults.BMJ Clin Evid2008https://conductscience.org/library/papers/19450297PubMed
18370513Meta-Analyses of Cisapride, Omeprazole and Ranitidine in the Treatment of GORD: Implications for Treating Patient Subgroups.Clin Drug Investig1998https://conductscience.org/library/papers/18370513PubMed
17431508Endoscopic treatment for gastroesophageal reflux disease: should you learn the techniques?Can J Gastroenterol2007https://conductscience.org/library/papers/17431508PubMed
17410461Acid-suppressive effects of various regimens of omeprazole in Helicobacter pylori-negative CYP2C19 homozygous extensive metabolizers: which regimen has the strongest effect?Dig Dis Sci2007https://conductscience.org/library/papers/17410461PubMed
16402242Pharmacokinetics of three proton pump inhibitors in Chinese subjects in relation to the CYP2C19 genotype.Eur J Clin Pharmacol2006https://conductscience.org/library/papers/16402242PubMed
15700122[Reflux esophagitis].Internist (Berl)2005https://conductscience.org/library/papers/15700122PubMed
15082617A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials.Gut2004https://conductscience.org/library/papers/15082617PubMed
14560364Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma.World J Surg2003https://conductscience.org/library/papers/14560364PubMed
12170024Medical or surgical therapy for erosive reflux esophagitis: cost-utility analysis using a Markov model.Ann Surg2002https://conductscience.org/library/papers/12170024PubMed
12141885On-demand and intermittent therapy for gastro-oesophageal reflux disease: economic considerations.Pharmacoeconomics2002https://conductscience.org/library/papers/12141885PubMed
12010078Lansoprazole for maintenance of remission of erosive oesophagitis.Drugs2002https://conductscience.org/library/papers/12010078PubMed
11723599Gastroesophageal reflux in infants and children. When to reassure and when to go further.Can Fam Physician2001https://conductscience.org/library/papers/11723599PubMed
11559645Reducing community dyspepsia drug costs: a controlled trial.Gut2001https://conductscience.org/library/papers/11559645PubMed

See all 40 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GAST2520PubTator's text mininghttps://conductscience.org/library/genes/2520

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8200548

GET https://conductscience.org/api/papers/v1/8200548/cited_by?page=2